Results 191 to 200 of about 33,296 (267)

From Bailout to Benchmark? Rethinking the Alfieri Procedure for Mitral Regurgitation in Barlow's Disease. [PDF]

J Clin Med
Steiner K, Voss B, Lang M, Bozini N, Soulis S, Bichler M, Bonk MN, Voss S, Vitanova K, Krane M, Sideris K.   +10 more
europepmc   +1 more source

Unveiling New Insights: Reinterpreting DES Mutation, p.Arg383His, Through a Study of an Iranian Family With Isolated Hypertrophic Cardiomyopathy, Implication for Phenotype–Genotype Correlation Analysis

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Desmin, a crucial intermediate filament in muscle cells, maintains structural integrity in cardiac muscle and provides stability to striated muscle cells. Mutations in the DES gene lead to desminopathies, causing diverse cardiac and skeletal myopathies.
Saeideh Kavousi, Farzad Kamali, Bahareh Rabbani, Mehrdad Behmanesh, Nejat Mahdieh, Mehrdad Noruzinia   +5 more
wiley   +1 more source

Severe Aortic and Mitral Regurgitation Secondary to Infective Endocarditis Presenting as Acute Respiratory Failure. [PDF]

Cureus
Mange M, Sharma D, Eddula M, Sharma P.
europepmc   +1 more source

Evidence‐Based Nursing Management During Mavacamten Therapy in an 89‐Year‐Old Patient With Symptomatic Hypertrophic Obstructive Cardiomyopathy: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT In older patients receiving mavacamten, a reduction in NT‐proBNP levels may coexist with persistent severe LVOTO. Nurses should interpret this biomarker–echocardiography discordance as a safety signal and maintain structured cardiovascular surveillance rather than assuming treatment success based solely on biomarker improvement.
Feifei Wang
wiley   +1 more source

Evaluating the impact of Lutetium-177 therapy on bioprosthetic heart valves in carcinoid heart disease. [PDF]

Cardiooncology
Scalia IG, Abdelfattah FE, Farina JM, Ibrahim OH, Awad K, Crestanello JA, Schaff HV, Halfdanarson TR, Ray JC, Pellikka PA, Connolly HM, Arsanjani R, Ayoub C.   +12 more
europepmc   +1 more source

Impella‐Assisted High‐Risk Percutaneous Coronary Intervention in Cardiogenic Shock With Low‐Flow, Low‐Gradient Aortic Stenosis and Multivessel Coronary Artery Disease: A Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Patients with cardiogenic shock, low‐flow, low‐gradient aortic stenosis, and multivessel coronary artery disease who are ineligible for surgery present a major therapeutic challenge. Percutaneous mechanical circulatory support may facilitate revascularization in this high‐risk population. A 69‐year‐old man presented after a mechanical fall and
Douni Roger, Waleed Shaker, Zan Siddiqi, George Abela   +3 more
wiley   +1 more source

A monolithic patient-specific 3D-0D model for In silico investigation of hemodynamics in patients with left ventricular assist devices. [PDF]

Biomech Model Mechanobiol
Bonini M, Hirschvogel M, Ferguson M, Pagani F, Tang PC, Nordsletten D.   +5 more
europepmc   +1 more source

Simultaneous Heart–Kidney Transplantation for Ebstein's Anomaly: A Viable Treatment Option in Latin America

Clinical Case Reports, Volume 14, Issue 8, August 2026.
Chest x‐ray showing a typical presentation of Ebstein anomaly with severe cardiomegaly and a prominent right atrium silhouette. ABSTRACT Simultaneous heart–kidney transplantation is a viable and effective treatment option for patients with congenital heart disease and advanced chronic kidney disease when both conditions threaten survival.
Edgar García‐Cruz, Andrea Luna‐Hernández, Jesús Alberto Blanco‐Hernández, Jorge Sánchez‐Nieto, Stephanie Teresa Angulo‐Cruzado, Karla Alejandra Pupiales‐Dávila, Carla Domínguez‐Pereyra, Reyna Moreno‐Ruíz, Carlos Antonio Villegas‐Chávez, Antonio Jordán‐Ríos, Daniel Manzur‐Sandoval, Victor Alejandro Quiroz‐Martínez, Francisco Martín Baranda‐Tovar   +12 more
wiley   +1 more source

A Case of Fulminant Infective Endocarditis in Mitral Valve Prolapse With Septic Emboli and an Annular Abscess. [PDF]

Cureus
Smith RL, Jules P, Clark R.
europepmc   +1 more source

Impact of Severe Postoperative Multi‐Organ Dysfunction on Long‐Term Outcomes After Modified Morrow Surgery

Clinical Cardiology, Volume 49, Issue 8, August 2026.
This retrospective cohort study (n = 380) demonstrates that severe postoperative multi‐organ dysfunction (SOFA Maximum ≥ 11) is a strong independent predictor of long‐term adverse outcomes after modified Morrow surgery. Incorporating the SOFA score into postoperative assessments helps identify high‐risk hypertrophic obstructive cardiomyopathy patients ...
Tong Wang, La Ta, Kui Zhang, Ran Dong, Yu Xiao, Jiayang Wang   +5 more
wiley   +1 more source